Bank of America spends over $250 million a year on employee GLP-1 drugs
- 1Bank of America CEO Brian Moynihan told CNBC that the cost of GLP-1 weight-loss drugs for employees exceeds $250 million annually
- 2GLP-1 drugs account for roughly 13% of the more than $2 billion in annual healthcare costs for the company's approximately 211,000 employees, up from zero 4-5 years ago
- 3Moynihan said the impact on employees is significant and called it a good investment in terms of long-term health benefits
This 3-line summary is compiled from the report below.
CNBC View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다